135 related articles for article (PubMed ID: 9573685)
21. Achromobacter xylosoxidans isolated from the sputum of a patient with cystic fibrosis mutation I1234V with Pseudomonas aeruginosa.
Abdul Wahab A; Janahi IA; El-Shafie SS
Saudi Med J; 2004 Jun; 25(6):810-1. PubMed ID: 15195220
[No Abstract] [Full Text] [Related]
22. Clinical and microbiological evaluation of eight patients with isolated Achromobacter xylosoxidans.
Atalay S; Ece G; Samlioğlu P; Kose S; Maras G; Gonullu M
Scand J Infect Dis; 2012 Oct; 44(10):798-801. PubMed ID: 22404460
[TBL] [Abstract][Full Text] [Related]
23. Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases.
Gómez-Cerezo J; Suárez I; Ríos JJ; Peña P; García de Miguel MJ; de José M; Monteagudo O; Linares P; Barbado-Cano A; Vázquez JJ
Eur J Clin Microbiol Infect Dis; 2003 Jun; 22(6):360-3. PubMed ID: 12750959
[TBL] [Abstract][Full Text] [Related]
24. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature.
Duggan JM; Goldstein SJ; Chenoweth CE; Kauffman CA; Bradley SF
Clin Infect Dis; 1996 Sep; 23(3):569-76. PubMed ID: 8879782
[TBL] [Abstract][Full Text] [Related]
25. Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans.
Teng SO; Ou TY; Hsieh YC; Lee WC; Lin YC; Lee WS
J Microbiol Immunol Infect; 2009 Apr; 42(2):176-80. PubMed ID: 19597652
[TBL] [Abstract][Full Text] [Related]
26. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
27. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subspecies xylosoxidans) bacteremia after liver transplantation.
Dupon M; Winnock S; Rogues AM; Janvier G; de Barbeyrac B; Saric J
Intensive Care Med; 1993; 19(8):480. PubMed ID: 8294634
[No Abstract] [Full Text] [Related]
28. [Bacteremia by Alcaligenes xylosoxidans: report of a case].
Torres L; Gorricho J; Fortuño B; Marco ML
Med Clin (Barc); 1997 Jun; 109(4):158-9. PubMed ID: 9289534
[No Abstract] [Full Text] [Related]
29. Infection of a total hip prosthesis in a dog caused by Achromobacter(Alcaligenes) xylosoxidans.
Girling SL; Innes JF
J Small Anim Pract; 2006 Dec; 47(12):747-50. PubMed ID: 17201829
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with mortality in bacteremic patients with hematologic malignancies.
Tumbarello M; Spanu T; Caira M; Trecarichi EM; Laurenti L; Montuori E; Fianchi L; Leone F; Fadda G; Cauda R; Pagano L
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):320-6. PubMed ID: 19345033
[TBL] [Abstract][Full Text] [Related]
31. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature.
Spear JB; Fuhrer J; Kirby BD
J Clin Microbiol; 1988 Mar; 26(3):598-9. PubMed ID: 3281982
[TBL] [Abstract][Full Text] [Related]
32. Agrobacterium radiobacter bacteremia in pediatric patients: case report and review.
Amaya RA; Edwards MS
Pediatr Infect Dis J; 2003 Feb; 22(2):183-6. PubMed ID: 12586984
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.
Wellinghausen N; Wirths B; Poppert S
J Clin Microbiol; 2006 Sep; 44(9):3415-7. PubMed ID: 16954289
[TBL] [Abstract][Full Text] [Related]
34. [Bacteremia and pneumonia due to Alcaligenes xylosoxidans in a immunocompetent patient].
Villamil I; Valdés R; Villacán MJ; Masa L
Rev Chilena Infectol; 2013 Jun; 30(3):329. PubMed ID: 23877784
[No Abstract] [Full Text] [Related]
35. A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: three case reports.
Asano K; Tada S; Matsumoto T; Miyase S; Kamio T; Sakurai K; Iida M
J Hepatol; 2005 Aug; 43(2):362-5. PubMed ID: 15978693
[TBL] [Abstract][Full Text] [Related]
36. Achromobacter xylosoxidans infection in baboons.
Mandrell TD
Lab Anim Sci; 1991 Oct; 41(5):506-8. PubMed ID: 1666159
[No Abstract] [Full Text] [Related]
37. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH
Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177
[TBL] [Abstract][Full Text] [Related]
38. Post-ERCP bacteremia caused by Alcaligenes xylosoxidans in a patient with pancreas cancer.
Yilmaz G; Aydin K; Koksal I; Caylan R; Akcay K; Arslan M
Ann Clin Microbiol Antimicrob; 2006 Sep; 5():19. PubMed ID: 16945159
[TBL] [Abstract][Full Text] [Related]
39. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study.
Martino R; Rámila E; Capdevila JA; Planes A; Rovira M; Ortega Md ; Plumé G; Gómez L; Sierra J
Clin Infect Dis; 2001 Aug; 33(4):E20-2. PubMed ID: 11462207
[TBL] [Abstract][Full Text] [Related]
40. Bacteremia by gram-negative bacilli in patients with hematologic malignancies. Comparison of the clinical presentation and outcome of infections by enterobacteria and non-glucose-fermenting gram-negative bacilli.
Martino R; Santamaría A; Muñoz L; Pericas R; Altés A; Prats G; Sierra J
Acta Haematol; 1999; 102(1):7-11. PubMed ID: 10473881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
